Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Hypertension | Research

A tryst of ‘blood pressure control- sex- comorbidities’: the odyssey of basic public health services in Yunnan in quest for truth

Authors: Linhong Pang, Lakshme Kottu, Zihong Guo, Min Ma, Huadan Wang, Yajing Zhao, Mingjing Tang, Yi Shi, Wei Liu, Xia Wu, Junjie Song, Manli Sun, Daphne Merkus, Md Misbahul Ferdous, Liping He, Lin Duo

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

The Basic Public Health Service (BPHS), a recently announced free healthcare program, aims to combat the most prevalent Noncommunicable Disease-“Hypertension” (HTN)-and its risk factors on a nationwide scale. In China, there is a rife that HTN less impacts women during their lifetime. We, therefore, aimed to evaluate the sex disparity in hypertension patients with comorbidities among south-west Chinese and the contribution of BPHS to address that concern.

Methods

We have opted for a multistage stratified random sampling method to enroll hypertensive patients of 35 years and older, divided them into BPHS and non-BPHS groups. We assessed the sex disparity in HTN patients with four major comorbidities- Dyslipidemia, Diabetes Mellitus (DM), Cardiovascular Disease (CVD), and Chronic Kidney Disease (CKD), and descriptive data were compiled. Odds ratios from logistic regression models estimated the effectiveness of BPHS in the management of HTN with comorbidities.

Results

Among 1521 hypertensive patients,1011(66.5%) were managed in the BPHS group. The proportion of patients who had at least one comorbidity was 70.7% (95% confidence interval [CI]: 66.3-76.8%), patients aged 65 years and older were more likely to have coexisting comorbidities. Participants who received the BPHS showed significant blood pressure (BP) control with two comorbidities (odds ratio [OR] = 2.414, 95% CI: 1.276–4.570), three or more (OR = 5.500, 95%CI: 1.174–25.756). Patients with dyslipidemia and DM also benefited from BPHS in controlling BP (OR = 2.169, 95% CI: 1.430–3.289) and (OR = 2.785, 95%CI: 1.242–6.246), respectively. In certain high-income urban survey centers, there was sex differences in the HTN management provided by BPHS, with men having better BP control rates than women.

Conclusions

Perhaps this is the first study in China to succinctly show the effectiveness and sex disparity regarding “management of hypertensive comorbidities”. This supports that the BPHS program plays a pivotal role in controlling BP, therefore should recommend the national healthcare system to give women a foremost priority in BPHS, especially to those from low-socioeconomic and low-scientific literacy regions.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
2.
go back to reference Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.PubMedPubMedCentralCrossRef Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.PubMedPubMedCentralCrossRef
3.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in Hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in Hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.CrossRef
4.
go back to reference Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and Hypertension. Nat Rev Cardiol. 2021;18(11):785–802.PubMedPubMedCentralCrossRef Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and Hypertension. Nat Rev Cardiol. 2021;18(11):785–802.PubMedPubMedCentralCrossRef
5.
6.
go back to reference Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of Hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–56.PubMedCrossRef Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of Hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–56.PubMedCrossRef
7.
go back to reference Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.PubMedCrossRef Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.PubMedCrossRef
8.
go back to reference Alsaadon H, Afroz A, Karim A, Habib SH, Alramadan MJ, Billah B, et al. Hypertension and its related factors among patients with type 2 Diabetes Mellitus - a multi-hospital study in Bangladesh. BMC Public Health. 2022;22(1):198.PubMedPubMedCentralCrossRef Alsaadon H, Afroz A, Karim A, Habib SH, Alramadan MJ, Billah B, et al. Hypertension and its related factors among patients with type 2 Diabetes Mellitus - a multi-hospital study in Bangladesh. BMC Public Health. 2022;22(1):198.PubMedPubMedCentralCrossRef
9.
go back to reference Shrestha PL, Shrestha PA, Vivo RP. Epidemiology of comorbidities in patients with Hypertension. Curr OpinCardiol. 2016;31(4):376–80. Shrestha PL, Shrestha PA, Vivo RP. Epidemiology of comorbidities in patients with Hypertension. Curr OpinCardiol. 2016;31(4):376–80.
10.
go back to reference Chen Y, Zhou ZF, Han JM, Jin X, Dong ZF, Liu L, et al. Patients with comorbid coronary artery Disease and Hypertension: a cross-sectional study with data from the NHANES. Ann Transl Med. 2022;10(13):745.PubMedPubMedCentralCrossRef Chen Y, Zhou ZF, Han JM, Jin X, Dong ZF, Liu L, et al. Patients with comorbid coronary artery Disease and Hypertension: a cross-sectional study with data from the NHANES. Ann Transl Med. 2022;10(13):745.PubMedPubMedCentralCrossRef
11.
go back to reference Kennard L, O’Shaughnessy KM. Treating Hypertension in patients with medical comorbidities. BMJ. 2016;352:i101.PubMedCrossRef Kennard L, O’Shaughnessy KM. Treating Hypertension in patients with medical comorbidities. BMJ. 2016;352:i101.PubMedCrossRef
12.
go back to reference Narita K, Hoshide S, Kario K. Difference between morning and evening home blood pressure and cardiovascular events: the J-HOP study (Japan Morning Surge-Home blood pressure). Hypertens Res. 2021;44(12):1597–605.PubMedCrossRef Narita K, Hoshide S, Kario K. Difference between morning and evening home blood pressure and cardiovascular events: the J-HOP study (Japan Morning Surge-Home blood pressure). Hypertens Res. 2021;44(12):1597–605.PubMedCrossRef
13.
go back to reference Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning Hypertension: the strongest Independent risk factor for Stroke in Elderly Hypertensive patients. Hypertens Res. 2006;29(8):581–7.PubMedCrossRef Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning Hypertension: the strongest Independent risk factor for Stroke in Elderly Hypertensive patients. Hypertens Res. 2006;29(8):581–7.PubMedCrossRef
14.
go back to reference Hoshide S, Kubota K, Kario K. Difference between morning and evening blood pressure at home and nocturnal hypoxia in the general practitioner-based. J-HOP Study Hypertens Res. 2023;46(3):751–5.PubMedCrossRef Hoshide S, Kubota K, Kario K. Difference between morning and evening blood pressure at home and nocturnal hypoxia in the general practitioner-based. J-HOP Study Hypertens Res. 2023;46(3):751–5.PubMedCrossRef
15.
go back to reference Xu Y, Möller J, Wang R, Liang Y. Life-course blood pressure trajectories and Cardiovascular Diseases: a population-based cohort study in China. PLoS ONE. 2020;15(10):e0240804.PubMedPubMedCentralCrossRef Xu Y, Möller J, Wang R, Liang Y. Life-course blood pressure trajectories and Cardiovascular Diseases: a population-based cohort study in China. PLoS ONE. 2020;15(10):e0240804.PubMedPubMedCentralCrossRef
16.
go back to reference Connelly PJ, Currie G, Delles C. Sex differences in the prevalence, outcomes and Management of Hypertension. CurrHypertens Rep. 2022;24(6):185–92. Connelly PJ, Currie G, Delles C. Sex differences in the prevalence, outcomes and Management of Hypertension. CurrHypertens Rep. 2022;24(6):185–92.
17.
go back to reference Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14(3):201–12.PubMedPubMedCentralCrossRef Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14(3):201–12.PubMedPubMedCentralCrossRef
18.
go back to reference Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 update: a Report from the American Heart Association. Circulation. 2021;143(8):e254–e743.PubMedCrossRef Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 update: a Report from the American Heart Association. Circulation. 2021;143(8):e254–e743.PubMedCrossRef
19.
go back to reference DeGuire J, Clarke J, Rouleau K, Roy J, Bushnik T. Blood pressure and Hypertension. Health Rep. 2019;30(2):14–21.PubMed DeGuire J, Clarke J, Rouleau K, Roy J, Bushnik T. Blood pressure and Hypertension. Health Rep. 2019;30(2):14–21.PubMed
20.
go back to reference Neufcourt L, Deguen S, Bayat S, Paillard F, Zins M, Grimaud O. Geographical variations in the prevalence of hypertensionin France: cross-sectional analysis of the CONSTANCES cohort. Eur J PrevCardiol. 2019;26(12):1242–51. Neufcourt L, Deguen S, Bayat S, Paillard F, Zins M, Grimaud O. Geographical variations in the prevalence of hypertensionin France: cross-sectional analysis of the CONSTANCES cohort. Eur J PrevCardiol. 2019;26(12):1242–51.
21.
go back to reference Fenech G, Vallée A, Cherfan M, Kab S, Goldberg M, Zins M, et al. Poor awareness of Hypertension in France: the CONSTANCES Population-based study. Am J Hypertens. 2020;33(6):543–51.PubMedCrossRef Fenech G, Vallée A, Cherfan M, Kab S, Goldberg M, Zins M, et al. Poor awareness of Hypertension in France: the CONSTANCES Population-based study. Am J Hypertens. 2020;33(6):543–51.PubMedCrossRef
22.
go back to reference Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to Understand Sex differences in Cardiovascular Disease. Can J Cardiol. 2021;37(5):699–710.PubMedCrossRef Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to Understand Sex differences in Cardiovascular Disease. Can J Cardiol. 2021;37(5):699–710.PubMedCrossRef
23.
go back to reference Song J-J, Ma Z, Wang J, Chen L-X, Zhong J-C. Gender differences in Hypertension. J Cardiovasc Transl Res. 2020;13(1):47–54.PubMedCrossRef Song J-J, Ma Z, Wang J, Chen L-X, Zhong J-C. Gender differences in Hypertension. J Cardiovasc Transl Res. 2020;13(1):47–54.PubMedCrossRef
24.
go back to reference Cao B, Bray F, Ilbawi A, Soerjomataram I. Effect on longevity of one-third reduction in premature mortality from non-communicable Diseases by 2030: a global analysis of the sustainable development goal health target. Lancet Glob Health. 2018;6(12):e1288–96.PubMedCrossRef Cao B, Bray F, Ilbawi A, Soerjomataram I. Effect on longevity of one-third reduction in premature mortality from non-communicable Diseases by 2030: a global analysis of the sustainable development goal health target. Lancet Glob Health. 2018;6(12):e1288–96.PubMedCrossRef
25.
go back to reference Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J, et al. Sex differences in the awareness, treatment, and control of hypertensionin China: a systematic review with meta-analyses. Hypertens Res. 2019;42(2):273–83.PubMedCrossRef Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J, et al. Sex differences in the awareness, treatment, and control of hypertensionin China: a systematic review with meta-analyses. Hypertens Res. 2019;42(2):273–83.PubMedCrossRef
26.
go back to reference Chen S, Guo L, Wang Z, Mao W, Ge Y, Ying X, et al. Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: a systematic analysis. PLoS Med. 2019;16(11):e1002975.PubMedPubMedCentralCrossRef Chen S, Guo L, Wang Z, Mao W, Ge Y, Ying X, et al. Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: a systematic analysis. PLoS Med. 2019;16(11):e1002975.PubMedPubMedCentralCrossRef
27.
go back to reference Whelton PK, Carey RM, Aronow WS, Casey DEJr, Collins KJ, Dennison Himmelfarb C, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. Whelton PK, Carey RM, Aronow WS, Casey DEJr, Collins KJ, Dennison Himmelfarb C, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
28.
go back to reference Bureau of Disease Prevention and Control. National Health Commission of people’s Republic of China. National guideline for Hypertension management in China. Zhonghua Xin xue guan bing za zhi. 2020;48:10–46. Bureau of Disease Prevention and Control. National Health Commission of people’s Republic of China. National guideline for Hypertension management in China. Zhonghua Xin xue guan bing za zhi. 2020;48:10–46.
29.
go back to reference Joint Committee for Guideline R. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16(3):182–241. Joint Committee for Guideline R. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16(3):182–241.
30.
go back to reference Li X, Lu J, Hu S, Cheng KK, De Maeseneer J, Meng Q, et al. The primary healthcare system in China. The Lancet. 2017;390(10112):2584–94.CrossRef Li X, Lu J, Hu S, Cheng KK, De Maeseneer J, Meng Q, et al. The primary healthcare system in China. The Lancet. 2017;390(10112):2584–94.CrossRef
32.
go back to reference Hao G, Chen Z, Wang X, Zhang L, Kang Y, Zheng C, et al. Evaluation of the community-based Hypertension Management Programs in China. Front Public Health. 2022;10:896603.PubMedPubMedCentralCrossRef Hao G, Chen Z, Wang X, Zhang L, Kang Y, Zheng C, et al. Evaluation of the community-based Hypertension Management Programs in China. Front Public Health. 2022;10:896603.PubMedPubMedCentralCrossRef
33.
go back to reference Pang L, Kottu L, Guo Z, Shi Y, Ferdous M, Zhao Y, et al. Dawning public health services dogma: an indigenous South-West Chinese perspective in managing hypertension-with or without the BPHS? Front Public Health. 2022;10:1017795.PubMedPubMedCentralCrossRef Pang L, Kottu L, Guo Z, Shi Y, Ferdous M, Zhao Y, et al. Dawning public health services dogma: an indigenous South-West Chinese perspective in managing hypertension-with or without the BPHS? Front Public Health. 2022;10:1017795.PubMedPubMedCentralCrossRef
34.
go back to reference Liang X, Chen J, Liu Y, He C, Li T. The effect of Hypertension and Diabetes management in South-West China: a before- and after-intervention study. PLoS ONE. 2014;9(3):e91801.PubMedPubMedCentralCrossRefADS Liang X, Chen J, Liu Y, He C, Li T. The effect of Hypertension and Diabetes management in South-West China: a before- and after-intervention study. PLoS ONE. 2014;9(3):e91801.PubMedPubMedCentralCrossRefADS
35.
go back to reference Yan C, Yuan Y, Zhao D, Li J, Fu P, Chen Y, et al. Family Doctor Contract services and awareness of blood pressure measurement among Hypertension patients: a cross-sectional study in rural Shandong, China. Front Public Health. 2022;10:757481.PubMedPubMedCentralCrossRef Yan C, Yuan Y, Zhao D, Li J, Fu P, Chen Y, et al. Family Doctor Contract services and awareness of blood pressure measurement among Hypertension patients: a cross-sectional study in rural Shandong, China. Front Public Health. 2022;10:757481.PubMedPubMedCentralCrossRef
36.
go back to reference Zheng X, Xiao F, Li R, Yin D, Xin Q, Yang H, et al. The effectiveness of Hypertension management in China: a community-based intervention study. Prim Health Care Res Dev. 2019;20:e111.PubMedPubMedCentralCrossRef Zheng X, Xiao F, Li R, Yin D, Xin Q, Yang H, et al. The effectiveness of Hypertension management in China: a community-based intervention study. Prim Health Care Res Dev. 2019;20:e111.PubMedPubMedCentralCrossRef
37.
go back to reference Fang G, Yang D, Wang L, Wang Z, Liang Y, Yang J. Experiences and Challenges of Implementing Universal Health Coverage with China’s National Basic Public Health Service Program: Literature Review, Regression Analysis, and Insider interviews. JMIR Public Health Surveill. 2022;8(7):e31289.PubMedPubMedCentralCrossRef Fang G, Yang D, Wang L, Wang Z, Liang Y, Yang J. Experiences and Challenges of Implementing Universal Health Coverage with China’s National Basic Public Health Service Program: Literature Review, Regression Analysis, and Insider interviews. JMIR Public Health Surveill. 2022;8(7):e31289.PubMedPubMedCentralCrossRef
38.
go back to reference Smith SM, Wallace E, O’Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2021;1(1):Cd006560.PubMed Smith SM, Wallace E, O’Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2021;1(1):Cd006560.PubMed
39.
go back to reference Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. The association between Smoking and blood pressure in men: a cross-sectional study. BMC Public Health. 2017;17(1):797.PubMedPubMedCentralCrossRef Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. The association between Smoking and blood pressure in men: a cross-sectional study. BMC Public Health. 2017;17(1):797.PubMedPubMedCentralCrossRef
40.
go back to reference Li Z, Yu S, Han X, Liu J, Yao H. Changes to cardiovascular risk factors over 7 years: a prospective cohort study of in situ urbanised residents in the Chaoyang District of Beijing. BMJ Open. 2020;10(3):e033548.PubMedPubMedCentralCrossRef Li Z, Yu S, Han X, Liu J, Yao H. Changes to cardiovascular risk factors over 7 years: a prospective cohort study of in situ urbanised residents in the Chaoyang District of Beijing. BMJ Open. 2020;10(3):e033548.PubMedPubMedCentralCrossRef
41.
go back to reference Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related Diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.PubMed Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related Diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.PubMed
42.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic Kidney Disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic Kidney Disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef
43.
go back to reference Hoshide S, Mogi M, Kario K. The next stage of Hypertension management in Asia. Hypertens Res. 2022;45(10):1552.PubMedCrossRef Hoshide S, Mogi M, Kario K. The next stage of Hypertension management in Asia. Hypertens Res. 2022;45(10):1552.PubMedCrossRef
44.
go back to reference Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of Hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.PubMedCrossRef Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of Hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.PubMedCrossRef
45.
go back to reference Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial Hypertension: the Task Force for the management of arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.PubMedCrossRef Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial Hypertension: the Task Force for the management of arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.PubMedCrossRef
46.
go back to reference Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of Hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32(1):3–15.PubMedCrossRef Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of Hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32(1):3–15.PubMedCrossRef
47.
go back to reference James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of High Blood Pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.PubMedCrossRef James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of High Blood Pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.PubMedCrossRef
48.
go back to reference Ghazi L, Oparil S. Impact of the SPRINT Trial on Hypertension Management. Annu Rev Med. 2018;69:81–95.PubMedCrossRef Ghazi L, Oparil S. Impact of the SPRINT Trial on Hypertension Management. Annu Rev Med. 2018;69:81–95.PubMedCrossRef
49.
go back to reference Nilsson P. What is the optimal blood pressure in patients with Diabetes Mellitus? Am J Cardiovasc Drugs. 2001;1(3):173–7.PubMedCrossRef Nilsson P. What is the optimal blood pressure in patients with Diabetes Mellitus? Am J Cardiovasc Drugs. 2001;1(3):173–7.PubMedCrossRef
50.
go back to reference Herberth J, Soliman KM, Fülöp T, Basile JN. How we got where we are in blood pressure targets. Curr Hypertens Rep. 2021;23(6):33.PubMedCrossRef Herberth J, Soliman KM, Fülöp T, Basile JN. How we got where we are in blood pressure targets. Curr Hypertens Rep. 2021;23(6):33.PubMedCrossRef
51.
go back to reference Chen L, Tonkin AM, Moon L, Mitchell P, Dobson A, Giles G, et al. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart. Eur J Cardiovasc Prev Rehabil. 2009;16(5):562–70.PubMedCrossRef Chen L, Tonkin AM, Moon L, Mitchell P, Dobson A, Giles G, et al. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart. Eur J Cardiovasc Prev Rehabil. 2009;16(5):562–70.PubMedCrossRef
52.
go back to reference Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal Cardiovascular Disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003.PubMedCrossRef Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal Cardiovascular Disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003.PubMedCrossRef
53.
go back to reference Paulsen MS, Andersen M, Thomsen JL, Schroll H, Larsen PV, Lykkegaard J, et al. Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice. J Am Heart Assoc. 2012;2(1):e004531.PubMedCrossRef Paulsen MS, Andersen M, Thomsen JL, Schroll H, Larsen PV, Lykkegaard J, et al. Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice. J Am Heart Assoc. 2012;2(1):e004531.PubMedCrossRef
54.
go back to reference Joint committee for guideline r. 2016 Chinese guidelines for the management of dyslipidemia in adults. J GeriatrCardiol. 2018;15(1):1–29. Joint committee for guideline r. 2016 Chinese guidelines for the management of dyslipidemia in adults. J GeriatrCardiol. 2018;15(1):1–29.
55.
go back to reference Chinese Diabetes Society. National guidelines for the prevention and control of Diabetes in primary care. ZhonghuaNeiKe Za Zhi. 2018;57:885–93. Chinese Diabetes Society. National guidelines for the prevention and control of Diabetes in primary care. ZhonghuaNeiKe Za Zhi. 2018;57:885–93.
56.
go back to reference Kidney Disease. Improving global outcomes (KDIGO) Diabetes Work Group.KDIGO 2022 Clinical Practice Guideline for Diabetes Management in chronic Kidney Disease. Kidney Int. 2022;102(5s):1–s127. Kidney Disease. Improving global outcomes (KDIGO) Diabetes Work Group.KDIGO 2022 Clinical Practice Guideline for Diabetes Management in chronic Kidney Disease. Kidney Int. 2022;102(5s):1–s127.
57.
go back to reference Li YT, Wang HHX, Liu KQL, Lee GKY, Chan WM, Griffiths SM, et al. Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: a cross-sectional analysis. Med (Baltim). 2016;95(20):e3572.CrossRef Li YT, Wang HHX, Liu KQL, Lee GKY, Chan WM, Griffiths SM, et al. Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: a cross-sectional analysis. Med (Baltim). 2016;95(20):e3572.CrossRef
58.
go back to reference Sarkar C, Dodhia H, Crompton J, Schofield P, White P, Millett C, et al. Hypertension: a cross-sectional study of the role of multimorbidity in blood pressure control. BMC Fam Pract. 2015;16:98.PubMedPubMedCentralCrossRef Sarkar C, Dodhia H, Crompton J, Schofield P, White P, Millett C, et al. Hypertension: a cross-sectional study of the role of multimorbidity in blood pressure control. BMC Fam Pract. 2015;16:98.PubMedPubMedCentralCrossRef
59.
go back to reference Hypertensive Group of Chinese Society of Cardiology of Chinese Medical Association. Editorial Board of Chinese Journal of Cardiology.Expert consensus on the comprehensive management of blood pressure and dyslipidemia in Chinese hypertensive patients. Zhonghua Xin xue guan bing za zhi. 2021;49:554–63. Hypertensive Group of Chinese Society of Cardiology of Chinese Medical Association. Editorial Board of Chinese Journal of Cardiology.Expert consensus on the comprehensive management of blood pressure and dyslipidemia in Chinese hypertensive patients. Zhonghua Xin xue guan bing za zhi. 2021;49:554–63.
60.
go back to reference Xing L, Jing L, Tian Y, Yan H, Zhang B, Sun Q, et al. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: a cross-sectional study. NutrMetab Cardiovasc Dis. 2020;30(12):2262–70.CrossRef Xing L, Jing L, Tian Y, Yan H, Zhang B, Sun Q, et al. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: a cross-sectional study. NutrMetab Cardiovasc Dis. 2020;30(12):2262–70.CrossRef
61.
go back to reference Zhang G, Yu C, Zhou M, Wang L, Zhang Y, Luo L. Burden of ischaemic Heart Disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of Disease 2015 study. BMC Cardiovasc Disord. 2018;18(1):18.PubMedPubMedCentralCrossRef Zhang G, Yu C, Zhou M, Wang L, Zhang Y, Luo L. Burden of ischaemic Heart Disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of Disease 2015 study. BMC Cardiovasc Disord. 2018;18(1):18.PubMedPubMedCentralCrossRef
62.
go back to reference Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990–2015. JAMA. 2017;317(2):165–82.PubMedCrossRef Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990–2015. JAMA. 2017;317(2):165–82.PubMedCrossRef
63.
go back to reference Li X, Cai L, Cui WL, Wang XM, Li HF, He JH, et al. Association of socioeconomic and lifestyle factors with chronic non-communicable Diseases and multimorbidity among the elderly in rural south-west China. J Public Health (Oxf). 2020;42(2):239–46.PubMedCrossRef Li X, Cai L, Cui WL, Wang XM, Li HF, He JH, et al. Association of socioeconomic and lifestyle factors with chronic non-communicable Diseases and multimorbidity among the elderly in rural south-west China. J Public Health (Oxf). 2020;42(2):239–46.PubMedCrossRef
64.
go back to reference Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M et al. Prevalence of chronic Kidney Disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1). Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M et al. Prevalence of chronic Kidney Disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1).
66.
go back to reference Zhang R, Chen Y, Liu S, Liang S, Wang G, Li L, et al. Progress of equalizing basic public health services in South-West China— health education delivery in primary healthcare sectors. BMC Health Serv Res. 2020;20(1):247.PubMedPubMedCentralCrossRef Zhang R, Chen Y, Liu S, Liang S, Wang G, Li L, et al. Progress of equalizing basic public health services in South-West China— health education delivery in primary healthcare sectors. BMC Health Serv Res. 2020;20(1):247.PubMedPubMedCentralCrossRef
67.
go back to reference Zhou T, Wang Y, Zhang H, Wu C, Tian N, Cui J, et al. Primary care institutional characteristics associated with Hypertension awareness, treatment, and control in the China PEACE-Million persons Project and primary healthcare survey: a cross-sectional study. Lancet Glob Health. 2023;11(1):e83–e94.PubMedCrossRef Zhou T, Wang Y, Zhang H, Wu C, Tian N, Cui J, et al. Primary care institutional characteristics associated with Hypertension awareness, treatment, and control in the China PEACE-Million persons Project and primary healthcare survey: a cross-sectional study. Lancet Glob Health. 2023;11(1):e83–e94.PubMedCrossRef
68.
go back to reference Buawangpong N, Pinyopornpanish K, Jiraporncharoen W, Dejkriengkraikul N, Sagulkoo P, Pateekhum C, Angkurawaranon C. Incorporating the patient-centered approach into clinical practice helps improve quality of care in cases of Hypertension: a retrospective cohort study. BMC Fam Pract. 2020;21(1):108.PubMedPubMedCentralCrossRef Buawangpong N, Pinyopornpanish K, Jiraporncharoen W, Dejkriengkraikul N, Sagulkoo P, Pateekhum C, Angkurawaranon C. Incorporating the patient-centered approach into clinical practice helps improve quality of care in cases of Hypertension: a retrospective cohort study. BMC Fam Pract. 2020;21(1):108.PubMedPubMedCentralCrossRef
69.
go back to reference Thangsuk P, Pinyopornpanish K, Jiraporncharoen W, Buawangpong N, Angkurawaranon C. Is the Association between Herbal Use and blood-pressure control mediated by Medication Adherence? A cross-sectional study in primary care. Int J Environ Res Public Health 2021, 18(24). Thangsuk P, Pinyopornpanish K, Jiraporncharoen W, Buawangpong N, Angkurawaranon C. Is the Association between Herbal Use and blood-pressure control mediated by Medication Adherence? A cross-sectional study in primary care. Int J Environ Res Public Health 2021, 18(24).
70.
go back to reference Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity Nat Rev Dis Primers. 2022;8(1):48.PubMedCrossRef Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity Nat Rev Dis Primers. 2022;8(1):48.PubMedCrossRef
71.
go back to reference Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in Hypertension treatment, drug utilization patterns, and blood pressure control among US adults with Hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008;21(7):789–98.PubMedCrossRef Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in Hypertension treatment, drug utilization patterns, and blood pressure control among US adults with Hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008;21(7):789–98.PubMedCrossRef
72.
go back to reference Griffin BL, Bolch CA, Bourjeily G, Madsen TE, Hasnain M, McGregor AJ, et al. Hypertension: are current guidelines inclusive of sex and gender? J Womens Health (Larchmt). 2022;31(10):1391–6.PubMed Griffin BL, Bolch CA, Bourjeily G, Madsen TE, Hasnain M, McGregor AJ, et al. Hypertension: are current guidelines inclusive of sex and gender? J Womens Health (Larchmt). 2022;31(10):1391–6.PubMed
73.
go back to reference Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of Hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16(1):14–26.PubMedCrossRef Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of Hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16(1):14–26.PubMedCrossRef
74.
go back to reference Hoshide S, Mogi M, Kario K. Current status of Hypertension and treatment in Asia. Hypertens Res. 2022;45(7):1095–6.PubMedCrossRef Hoshide S, Mogi M, Kario K. Current status of Hypertension and treatment in Asia. Hypertens Res. 2022;45(7):1095–6.PubMedCrossRef
75.
go back to reference Kario K, Mogi M, Hoshide S. Latest Hypertension research to inform clinical practice in Asia. Hypertens Res. 2022;45(4):555–72.PubMedCrossRef Kario K, Mogi M, Hoshide S. Latest Hypertension research to inform clinical practice in Asia. Hypertens Res. 2022;45(4):555–72.PubMedCrossRef
Metadata
Title
A tryst of ‘blood pressure control- sex- comorbidities’: the odyssey of basic public health services in Yunnan in quest for truth
Authors
Linhong Pang
Lakshme Kottu
Zihong Guo
Min Ma
Huadan Wang
Yajing Zhao
Mingjing Tang
Yi Shi
Wei Liu
Xia Wu
Junjie Song
Manli Sun
Daphne Merkus
Md Misbahul Ferdous
Liping He
Lin Duo
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-17157-7

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue